ZACKS RESEARCH

FUNDS

PORTFOLIO

BROKER RESEARCH

MARKETS

SCREENING

EDUCATION

SERVICES

Earnings

EPS Surprises

Mutual Funds

Options

My Account

Help

Zacks Equity Research
Zacks Rank can tell you which stocks to buy and sell. Zacks Equity Research tells you why. Click here to learn more.

Quote:

Search for Ticker

Free Membership

Search:

ABC: Amerisourcebergen Corp - Full Company Report Enter Ticker:

Quote	Estimates	Charts	Company Reports	News	Financials

Full Company Report \| Estimates \| Brokerage Recommendations \| Comparison to Industry \| Insiders \| Brokerage Reports \| Zacks Equity Research \| Annual Report

AMERISOURCEBERGEN CORP (NYSE)
ABC	24.49	N/A	(N/A%)	Vol. 0	N/A ET

AmerisourceBergen Corporation is one of the world's largest pharmaceutical services companies serving the United States, Canada and selected global markets. Servicing both pharmaceutical manufacturers and healthcare providers in the pharmaceutical supply channel, the Company provides drug distribution and related services designed to reduce costs and improve patient outcomes. AmerisourceBergen's service solutions range from pharmacy automation and pharmaceutical packaging to pharmacy services for skilled nursing and assisted living facilities, reimbursement and pharmaceutical consulting services, and physician education.

General Information

AMERISOURCEBRGN

1300 Morris Drive Chesterbrook, PA 19087-5594 Phone: 610 727-7000 Fax: 610-647-0141 Web: www.amerisourcebergen.com Email: mkilpatric@amerisourcebergen.com

Industry	MED-WHSL DRG/SN
Sector:	Retail/Wholesale

Fiscal Year End	September
Last Reported Quarter	09/30/09
Next EPS Date	01/21/2010

Price and Volume Information

Zacks Rank
Yesterday's Close	24.49
52 Week High	24.85
52 Week Low	13.75
Beta	0.72
20 Day Moving Average	3,226,644.75
Target Price Consensus	26.03

% Price Change
4 Week	5.61
12 Week	15.52
YTD	37.35

% Price Change Relative to S&P 500
4 Week	4.47
12 Week	8.91
YTD	13.68

Share Information
Shares Outstanding (millions)	297.26
Market Capitalization (millions)	7,279.82
Short Ratio	2.70
Last Split Date	06/16/2009

Dividend Information
Dividend Yield	1.31%
Annual Dividend	$0.32
Payout Ratio	0.14
Change in Payout Ratio	0.06
Last Dividend Payout / Amount	11/19/2009 / $0.08

EPS Information
Current Quarter EPS Consensus Estimate	0.42
Current Year EPS Consensus Estimate	1.89
Estimated Long-Term EPS Growth Rate	12.20
Next EPS Report Date	01/21/2010

Consensus Recommendations
Current (1=Strong Buy, 5=Strong Sell)	1.64
30 Days Ago	1.64
60 Days Ago	1.64
90 Days Ago	1.50

Fundamental Ratios

P/E
Current FY Estimate:	12.98
Trailing 12 Months:	14.41
PEG Ratio	1.06

EPS Growth
vs. Previous Year	20.55%
vs. Previous Quarter	4.76%

Sales Growth
vs. Previous Year	9.08%
vs. Previous Quarter:	1.75%

Price Ratios
Price/Book	2.68
Price/Cash Flow	12.32
Price / Sales	0.10

ROE
09/30/09	18.66
06/30/09	18.12
03/31/09	17.94

ROA
09/30/09	3.98
06/30/09	3.97
03/31/09	3.97

Current Ratio
09/30/09	1.05
06/30/09	1.06
03/31/09	1.06

Quick Ratio
09/30/09	0.53
06/30/09	0.55
03/31/09	0.52

Operating Margin
09/30/09	0.71
06/30/09	0.71
03/31/09	0.70

Net Margin
09/30/09	1.15
06/30/09	1.14
03/31/09	1.12

Pre-Tax Margin
09/30/09	1.15
06/30/09	1.14
03/31/09	1.12

Book Value
09/30/09	9.14
06/30/09	9.22
03/31/09	9.06

Inventory Turnover
09/30/09	14.71
06/30/09	14.96
03/31/09	15.13

Debt-to-Equity
09/30/09	0.43
06/30/09	0.43
03/31/09	0.42

Debt to Capital
09/30/09	30.23
06/30/09	29.95
03/31/09	29.59


About Zacks \| Advertise \| Media \| Careers \| Contact Us \| Help Disclaimer \| Privacy Policy \| Sitemap NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed. Copyright 2009 Zacks Investment Research